BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22404848)

  • 1. Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain.
    Vandyk AD; Baker C
    Int J Ment Health Nurs; 2012 Aug; 21(4):349-57. PubMed ID: 22404848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
    Wong MM; Chen EY; Lui SS; Tso S
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lifestyle interventions and weight management in schizophrenia.
    Bushe C; Haddad P; Peveler R; Pendlebury J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):28-35. PubMed ID: 16280335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of weight gain in patients with schizophrenia.
    Aquila R
    J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The experience of weight gain as a result of taking second-generation antipsychotic medications: the mental health consumer perspective.
    Usher K; Park T; Foster K
    J Psychiatr Ment Health Nurs; 2013 Nov; 20(9):801-6. PubMed ID: 23146024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions to reduce weight gain in schizophrenia.
    Faulkner G; Cohn T; Remington G
    Schizophr Bull; 2007 May; 33(3):654-6. PubMed ID: 17449900
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of antipsychotic side effects on attitudes towards medication in people with schizophrenia and related disorders.
    Chiang YL; Klainin-Yobas P; Ignacio J; Chng CM
    J Clin Nurs; 2011 Aug; 20(15-16):2172-82. PubMed ID: 21539628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial processes influencing weight management among persons newly prescribed atypical antipsychotic medications.
    Xiao S; Baker C; Oyewumi LK
    J Psychiatr Ment Health Nurs; 2012 Apr; 19(3):241-7. PubMed ID: 22074295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide-induced weight loss in schizophrenia: case series.
    Yang J; Lee MS; Joe SH; Jung IK; Kim SH
    Clin Neuropharmacol; 2010; 33(2):104-6. PubMed ID: 19935403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
    Himmerich H; Schuld A; Pollmächer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.
    Das C; Mendez G; Jagasia S; Labbate LA
    Ann Clin Psychiatry; 2012 Aug; 24(3):225-39. PubMed ID: 22860242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric medication-induced obesity: treatment options.
    Schwartz TL; Nihalani N; Virk S; Jindal S; Chilton M
    Obes Rev; 2004 Nov; 5(4):233-8. PubMed ID: 15458397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-extrapyramidal motor side-effects in long-term therapy with neuroleptics: an analysis of 99 patients].
    Ginzel I; Hilger E; Barnas C
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):38-43. PubMed ID: 12407934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Double Whammy": Women's Experiences of Weight Gain After Diagnosis and Treatment for Schizophrenia Spectrum Disorders.
    Haracz K; Hazelton M; James C
    J Nerv Ment Dis; 2018 May; 206(5):303-309. PubMed ID: 29528882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic-associated weight gain and clinical outcome parameters.
    Blin O; Micallef J
    J Clin Psychiatry; 2001; 62 Suppl 7():11-21. PubMed ID: 11346191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.